참고문헌
- Armada, L. J., A. D. Mackey, and J. F. Gregory III. 2002. Intestinal brush border membrane catalyzes hydrolysis of pyridoxine-5'-beta-D-glucoside and exhibits parallel developmental changes of hydrolytic activities toward pyridoxine-5'-beta-D-glucoside and lactose in rats. J. Nutr. 132: 2695-2699
- Doucet J. 2005. Use of antidiabetic drugs in elderly patients. Diabetes Metab. 2: 977-5S98-5S104
- Casey, R. C., T. R. Jr. Oegema, K. M. Skubitz, S. E. Pambuccian, S. M. Grindle, and A. P. Skubitz. 2003. Cell membrane glycosylation mediates the adhesion, migration, and invasion of ovarian carcinoma cells. Clin. Exp. Metastasis 20: 143-152 https://doi.org/10.1023/A:1022670501667
- Dove, A. 2002. Seeking sweet relief for diabetes. Nat. Biotechnol. 20: 977-981 https://doi.org/10.1038/nbt1002-977
- Fischer, P. B., G. B. Karlsson, T. D. Butters, R. A. Dwek, and F. M. Platt. 1996. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120. J. Virol. 70: 7143-7152
- Fischer, P. B., G. B. Karlsson, R. A. Dwek, and F. M. Platt. 1996. N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with impaired gp120 shedding and gp41 exposure. J. Virol. 70: 7153-7160
- Gogas, H., F. Shapiro, C. Aghajanian, D. Fennelly, L. Almadrones, W. J. Hoskins, and D. R. Spriggs. 1996. The impact of diabetes mellitus on the toxicity of therapy for advanced ovarian cancer. Gynecol. Oncol. 61: 22-26 https://doi.org/10.1006/gyno.1996.0090
- Jenkins, D. J., R. H. Taylor, D. V. Goff, H. Fielden, J. J. Mis-iewicz, D. L. Sarson, S. R. Bloom, and K. G. Alberti. 1998. The anti-herpes simplex virus activity of n-docosanol includes inhibition of the viral entry process. Antiviral. Res. 40: 85-94 https://doi.org/10.1016/S0166-3542(98)00048-5
- Lee, D. S. and S. H. Lee. 2001. Genistein, a soy isoflavone, is a potent alpha-glucosidase inhibitor. FEBS Lett. 501: 84-86 https://doi.org/10.1016/S0014-5793(01)02631-X
- Peterson, G. 1995. Evaluation of the biochemical targets of quercetin in tumor cells. J. Nutr. 125(3 Suppl): 784S-789S
- Rosenstock, J., and P. Raskin. 1988. Hypertension in diabetes mellitus. Cardiol. Clin. 6: 547-560
- Santell, R. C., N. Kieu, and W. G. Helferich. 2000. Quercetin inhibits growth of estrogen-independent human breast cancer cells in culture but not in athymic mice. J. Nutr. 130: 1665-1669
- Segel, I. H. 1975. Enzyme kinetics: behavior and analysis of rapid equilibrium and steady-state enzyme system. Wiley, New York, p100-202
- Tadera K, Y. Minami, K. Takamatsu, and T. Matsuoka. 2006. Inhibition of alpha-glucosidase and alpha-amylase by flavonoids. J. Nutr. Sci. Vitaminol. (Tokyo). 52: 149-153 https://doi.org/10.3177/jnsv.52.149
- Tsujii, E., M. Muroi, N. Shiragami, and A. Takatsuki. 1996. Nectrisine is a potent inhibitor of alpha-glucosidases, demonstrating activities similarly at enzyme and cellular levels. Biochem. Biophys. Res. Commun. 220: 459-466 https://doi.org/10.1006/bbrc.1996.0427
- Walker, B. D., M. Kowalski, W. C. Goh, K. Kozarsky, M, Krieger, C. Rosen, L. Rohrschneider, W. A. Haseltine, and J. Sodroski. 1987. Inhibition of human immunodeficiency virus syncytium formation and virus replication by castanospermine. Proc. Natl. Acad. Sci. U.S.A. 84: 8120-8124
- de Groot H, and U. Rauen. 1998. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam. Clin. Pharmacol. 12: 249-255